C-Reactive Protein is a protein the liver releases into the blood when inflammatory signalling rises, and it is measured from an ordinary venous blood draw, usually inside a wider panel. A typical lab reference range runs from 0 to 3 mg/L. FitScript's optimal range is 0 to 1 mg/L, an optimization target rather than a diagnostic cut-off, and standard reference ranges vary by lab, age and sex. The marker is non-specific, so a number tells you that inflammatory activity is present, not where it comes from. The high-sensitivity version resolves the low end of the scale, which is what makes it useful for tracking background inflammation rather than obvious acute illness. For the full breakdown of the test, its ranges and how to read a single result, see the C-Reactive Protein guide.
Inflammation is the immune system's response to something it reads as a threat, and in short bursts it is useful rather than harmful. A cut, a virus, a hard training session, all of them trigger immune cells to release signalling molecules called cytokines. Those cytokines tell the liver to produce acute phase proteins, C-Reactive Protein among them, which is why a blood marker made in the liver can report on immune activity happening somewhere else entirely. When the threat clears, the signalling winds down and the markers drift back.
The version worth paying attention to is the one that does not wind down. Low-grade chronic inflammation is persistent, quiet signalling that never resolves, and it rarely announces itself with symptoms. People often describe vague versions of it, poor recovery from training, sleep that does not restore, joints that ache for no clear reason, but none of those are specific enough to act on.
That is the gap a blood panel fills. Instead of guessing from how you feel, you get a number that reflects what the immune system was doing on the day of the draw. The number does not explain itself, and it cannot name a cause, but it turns a vague question into something you can track across repeat measurements and discuss with a clinician using actual data rather than impressions.
It can, and the signal is clearest at the heavier end of the drinking spectrum. A systematic review and meta-analysis of inflammatory cytokines in alcohol use disorder found higher circulating levels of several pro-inflammatory cytokines in people with alcohol use disorder compared with controls 1. Research suggests that sustained heavy drinking is associated with a measurable shift in circulating inflammatory signalling, not only with how a person feels 1.
The link between those cytokines and the marker on your lab report is direct physiology. Cytokines released by immune cells travel to the liver, and the liver responds by producing acute phase proteins. So a rise in inflammatory signalling upstream tends to appear downstream as a higher C-Reactive Protein value. That is why an inflammation marker can move even when nothing feels wrong.
Two caveats keep this honest. First, the clearest findings come from people at the heavy end, so they do not tell you what a lighter pattern does to your personal numbers. Second, the marker is non-specific, which means a raised result after a period of drinking is consistent with alcohol contributing but does not prove alcohol caused it. What you can do is test, note your pattern, retest under similar conditions, and look at the direction of travel with a clinician who can see the rest of your panel.
Some of alcohol's inflammatory effect starts before the liver, in the intestine. The gut wall is a selective barrier, letting nutrients through while holding back bacteria and bacterial fragments. Research suggests that alcohol increases intestinal permeability, allowing bacterial products such as endotoxin to cross into the portal circulation and reach the liver, where they activate immune cells and drive inflammatory signalling 2.
This is the mechanism behind the phrase "leaky gut", a term that gets used loosely online but describes something real here. Blood from the intestine does not go straight into general circulation. It travels first through the portal vein into the liver, which acts as a filter staffed with resident immune cells. When more bacterial material arrives than usual, those cells respond the way they would to an infection, releasing inflammatory signals even though no infection exists.
The bacterial population itself also shifts. Changes in the gut microbiota are described as part of the inflammatory process in alcohol-associated liver disease 3. That matters practically, because it means the gut and the liver are not two separate stories. A person can have a liver panel that still reads inside range while the upstream barrier is already contributing signal, which is one reason a clinician reads inflammatory markers and liver enzymes together rather than one at a time.
The liver carries the metabolic load, and the intermediate step is the problem. Ethanol is converted to acetaldehyde, a reactive compound, before being converted again to acetate and cleared. While acetaldehyde is present it can bind to proteins and generate oxidative stress, and the liver cells doing the work are the ones most exposed to it.
Layered on top is the immune response. In alcohol-associated liver disease, activation of immune cells inside the liver sustains inflammation and contributes to tissue injury 3. Blood-based markers of inflammation are used to assess that inflammation without a biopsy 4, which is why a routine blood panel can carry useful information about an organ nobody is looking at directly.
Liver changes related to alcohol tend to progress quietly through stages, beginning with fat accumulation inside liver cells, which often produces no symptoms at all. That silence is the practical argument for testing rather than waiting. A person can feel entirely well while enzymes and inflammatory markers drift, and the first noticeable sign of a problem is rarely an early one. None of this means a single out-of-range liver enzyme indicates disease. It means the value is worth bringing to a clinician, who can place it next to your history, your other markers and a repeat draw.
Because part of what you are feeling is immune activity, not only dehydration. Research suggests that hangover involves inflammatory and immune changes alongside acetaldehyde exposure, disrupted sleep and neurochemical shifts 5. The symptom list overlaps heavily with being unwell for a reason. Fatigue, low mood, poor concentration, sensitivity to light and noise and general malaise are the same behavioural pattern the body produces during an infection.
That reframes the morning after. Water and sleep address part of it, but they do not switch off signalling that is already in motion, which is why people notice that recovery takes longer than rehydration should take. It also explains why training feels disproportionately hard the next day, and why sleep that looks long enough on paper leaves you unrestored.
There is a testing implication worth knowing. A blood draw taken during or immediately after a heavy episode can capture a transient state rather than your baseline. If the goal is to understand your usual level of background inflammation, the draw should happen in ordinary conditions, not in the aftermath of an unusual night. If the goal instead is to see what a particular pattern does to you, then the timing becomes part of the information, provided you record it and mention it when your results are reviewed.
Wine can raise inflammation, because the component doing most of the work is ethanol, and wine delivers ethanol like every other alcoholic drink. The gut barrier and liver pathways described above respond to ethanol itself, not to the beverage wrapped around it. Red wine's reputation comes largely from polyphenols such as resveratrol, which are present in genuinely small quantities, and they arrive packaged with the ethanol rather than instead of it.
There is also a separate phenomenon people confuse with inflammation. Some individuals notice flushing, headache or nasal congestion specifically with wine, which they attribute to histamine or other compounds in the drink. Whatever is behind that reaction, it is not the same thing as the sustained inflammatory signalling a blood marker tracks, and it is not a reliable guide to whether wine is affecting your labs.
The practical answer is that the drink type is a weaker variable than the pattern, the dose of ethanol over time and your own biology. If you want to know whether wine specifically affects you, the honest route is measurement rather than reasoning from the label. Test under consistent conditions, keep an accurate record of your real pattern, retest, and let a clinician interpret the direction alongside your liver enzymes and the rest of your panel.
No one can give you that number for your body, and anyone offering a universal threshold is generalising from populations to an individual. Alcohol metabolism varies with genetics, body composition, sex, liver status, gut health, sleep, medications prescribed by a clinician and the total load everything else is placing on the immune system.
Headlines about light drinking and heart health have swung in both directions for decades, and the back and forth is part of why the question feels unresolved. What no headline can report is where your own markers sit. Two people with identical weekly habits can produce different inflammatory profiles, and the difference matters more to them than any average.
So the useful reframe is from "how much is acceptable" to "what is my pattern doing to my numbers". That question has an answer, and the answer is specific to you. It comes from a baseline panel taken under ordinary conditions, an honest note of your actual drinking pattern, and a repeat panel after a defined period so the comparison means something.
This is also where expectations should stay calibrated. A single draw cannot isolate alcohol from sleep, training load, body composition and everything else moving at the same time. Across several draws, with the variables you can control kept steady, a trend becomes readable. A clinician is the person who should read it, because the interpretation depends on your history as much as on the values themselves.
A raised inflammatory marker means there was inflammatory activity in your body on the day of the draw. That is the observation, and it is reliable. What the value cannot do is name the cause, point to an organ or identify a condition, because the same marker rises for reasons as different as a head cold, a dental problem, a hard training block, a healing injury, excess body fat, smoking, poor sleep or an autoimmune condition.
So the inference stays hedged. A value above the typical reference range in someone who drinks regularly may reflect a contribution from alcohol, particularly when liver enzymes are drifting in the same direction, and it may equally reflect something unrelated that happened to coincide with the draw. A value inside the typical range does not rule alcohol out either, since the marker reports a moment in time.
The next step is the part that matters. Treat an out-of-range result as suboptimal and worth a conversation rather than as a verdict, and be straightforward with your clinician about recent illness, injury, training and drinking so the number can be read in context. A markedly raised inflammatory marker or liver enzyme is worth discussing with a clinician promptly, and no abnormal result should be ignored on the assumption that a known habit explains it.
Several routine labs move with sustained drinking, which is why no clinician reads an inflammation marker in isolation. Studies indicate that markers including gamma-glutamyl transferase, mean corpuscular volume, carbohydrate-deficient transferrin and the relationship between AST and ALT are used as indicators of excessive alcohol use 6.
| Marker | What it is | Why it comes up here |
|---|---|---|
| GGT (gamma-glutamyl transferase) | An enzyme concentrated in liver and bile duct cells | One of the routine liver enzymes clinicians review alongside drinking history |
| ALT (alanine aminotransferase) | An enzyme released when liver cells are stressed or damaged | Fairly specific to the liver, often read first in a liver panel |
| AST (aspartate aminotransferase) | An enzyme found in liver, muscle and other tissues | Less liver-specific, so the relationship between AST and ALT carries more information than either alone |
| MCV (mean corpuscular volume) | The average size of red blood cells, reported on a complete blood count | Already on most standard panels, so no extra draw is needed |
| CDT (carbohydrate-deficient transferrin) | A form of the iron transport protein transferrin | Ordered when a longer window on drinking is the specific question |
| hs-CRP | The high-sensitivity measure of C-Reactive Protein | Reports general inflammatory activity rather than liver-specific damage |
Blood-based inflammatory markers are also used to assess inflammation in alcohol-associated liver disease without a biopsy 4. None of these values names alcohol as the cause on its own. Each has other explanations, which is exactly why they are interpreted as a pattern, with your history, by a clinician.
Not necessarily, and assuming they do can mislead. Research suggests that inflammatory mechanisms related to alcohol use disorder and depression differ between men and women 7. Biology offers reasons to expect differences, including body water distribution, body composition and hormonal environment, all of which influence how a given amount of ethanol is handled and how the immune system responds.
This has three practical consequences. Reference ranges for some markers already differ by sex, so comparing your result to a generic number found online is a weak comparison. Hormonal status can shift inflammatory markers independently of alcohol, which means the timing of a draw within a cycle is worth noting. And the most informative comparison is almost always to your own previous result taken under similar conditions, not to a population average.
A finding describing a group tells you what tends to happen, not what is happening in you. The way to close that gap is personal data collected consistently, interpreted by someone who can see your whole panel. If you are tracking inflammation and drinking together, keep the conditions of each draw as similar as you can, and tell your clinician about anything that changed between draws.
Plenty, which is the main reason a single value cannot be pinned on alcohol. Infection is the most common contributor, and it does not need to be dramatic, since a cold, a sinus issue, a gum infection or a healing wound can all lift an inflammation marker for days. Recent intense or unfamiliar exercise can do the same, as can injury and recovery from surgery.
Body composition matters too, because adipose tissue is metabolically active rather than inert. Smoking, short or fragmented sleep, sustained psychological stress, autoimmune conditions and hormonal status all sit on the list of things that can move the number. Medications prescribed by a clinician can also influence inflammatory markers, which is one more reason the person interpreting your result should know your full history.
The practical response is to control what you can at the point of testing. Avoid scheduling a baseline draw in the middle of an illness, in the days after an unusually hard training session, or immediately following a period that was out of character for you. Keep the lab, the time of day and the fasting status consistent between draws so the comparison is fair. Then record what was happening around each test, because context turns an uninterpretable number into a usable one, and your clinician cannot account for a variable you did not mention.
These markers report current physiology rather than a permanent record, which is the hopeful part of the picture. Studies suggest that the available markers of excessive alcohol use differ in the time window they reflect, with some responding to recent intake and others reflecting longer patterns 6. That difference is useful, because it means a panel can distinguish between what happened last week and what has been happening for months.
What nobody can promise is a specific result on a specific timeline for a specific person. Whether an individual's markers move, how far and how quickly depends on how long the pattern ran, what else is driving inflammation, liver status, body composition and factors outside anyone's control. Promising a number would be inventing one.
So the honest approach is measurement. Establish a baseline, make the change you intend to make, hold the testing conditions steady, and retest after a period agreed with a clinician. The comparison between two well-matched draws tells you more than any general claim about recovery.
If results stay outside the standard range despite a sustained change, that is a reason to return to a clinician rather than to keep waiting. Persistent out-of-range liver enzymes or inflammatory markers deserve investigation, because something else may be contributing, and treatment decisions belong to a licensed provider who has reviewed your full picture.
Through a standard venous blood draw, usually bundled with a wider panel and often taken fasting because lipids and glucose are measured at the same time. There is no special preparation for an inflammation marker beyond consistency, and consistency is what makes repeat results comparable. Use the same lab where possible, the same approximate time of day and the same fasting status, and avoid testing during acute illness if you want a baseline.
A single reading is a snapshot. The value of this kind of testing comes from repetition, because a trend across several draws filters out the noise that any one day introduces. How frequently to retest is a decision for a clinician, who can weigh your history and what you are trying to answer. FitScript's membership is built around repeat measurement, with 150+ biomarkers tested per year and interpretation by Atlas, its AI health advisor, with a licensed provider deciding on any next step.
Several markers are worth having in the same panel as C-Reactive Protein when drinking is part of the question. A liver panel covering ALT, AST and GGT, a complete blood count that includes MCV, a lipid panel, fasting glucose or HbA1c, and ferritin all add context. Each is routine, and together they let a clinician see whether one isolated value is a blip or part of a pattern.
Any result outside the standard reference range is worth discussing, and a markedly raised inflammatory marker or liver enzyme is worth discussing with a clinician promptly. The same applies to values that keep climbing across repeat draws even when each individual number looks unremarkable, and to any result accompanied by symptoms such as persistent fatigue, upper abdominal discomfort, unexplained weight change, yellowing of the skin or eyes, or easy bruising.
It is also worth raising if drinking has become hard to control, or if cutting back has proved harder than expected. That is a clinical conversation with real support behind it, not a test of willpower, and bringing it to a clinician early means your labs can be read alongside the full context instead of in the dark.
Bring more than the number to that appointment. Your actual drinking pattern, recent illness, training load, sleep, anything prescribed by a clinician and your previous results all change how a value should be interpreted. A clinician who can see the trend and the context will give you a far more useful answer than any reference range read on its own.
This article is educational and not medical advice. Discuss your results and any treatment with a clinician or licensed provider before acting on anything you have read here.
If you want to see how drinking shows up elsewhere on a standard panel, the lipid side of the picture is covered in does alcohol increase triglycerides, which is often the next result people ask about after an inflammation marker comes back higher than expected.
A short-term rise is possible, because an inflammation marker reports what your immune system is doing around the time of the draw rather than your long-term average. That is why a blood test taken the morning after an unusual night may not represent your baseline. If you want a baseline reading, test under ordinary conditions and tell your clinician what was happening in the days before.
All three deliver ethanol, and ethanol is the component that drives the gut and liver pathways involved. Red wine's reputation comes from polyphenols, which are present in small amounts and arrive alongside the alcohol rather than instead of it. If you want to know how wine specifically affects you, measurement under consistent conditions is more reliable than reasoning from the drink type.
There is no single waiting period that applies to everyone, and the right answer depends on what you are trying to find out. If the goal is a baseline, test in ordinary conditions rather than straight after an unusual night or during an illness. Ask the clinician ordering the panel how to time the draw for your situation.
Yes. C-Reactive Protein is non-specific and reflects a moment in time, so a result inside the standard range does not rule out any particular contributor. This is one reason liver enzymes, a complete blood count and other markers are reviewed alongside it. A clinician looks at the whole panel and your history rather than one value.
A standard liver panel covering ALT, AST and GGT is the usual starting point, often alongside MCV from a complete blood count. Carbohydrate-deficient transferrin may be added when a longer window on drinking is the question. None of these names a cause on its own, so interpretation belongs to a clinician who knows your history.
FitScript's optimal range of 0 to 1 mg/L is an optimization target, not a diagnostic cut-off, so a value above it is best read as suboptimal rather than as a finding about a condition. It indicates inflammatory activity without identifying a source. Bring the result to a clinician, who can place it alongside your other markers and decide whether anything further is needed.
Nobody can give you a reliable timeline, because it depends on how long the pattern ran, what else is contributing and your overall health. The practical approach is to establish a baseline, keep testing conditions consistent and retest after a period agreed with a clinician. The comparison between two well-matched draws tells you more than any general expectation.
Contact a clinician about any value outside the standard reference range, and promptly if an inflammatory marker or liver enzyme is markedly raised or keeps climbing across repeat tests. Do the same if you notice persistent fatigue, upper abdominal discomfort, unexplained weight change or yellowing of the skin or eyes. If drinking has become hard to control, that is also worth raising, and any next step is a decision for a licensed provider.